Investigating the Anti-Inflammatory, Antioxidant and Apoptotic Protein Inhibition Study of Berberine on Diabetic Retinopathy in Rats
Lihui Wang1★, Wei Fei2★, Chongjuan Qin3★, Jing Zhang4★★ Corresponding author
- 1Department of Medical Imaging Center, Jinan Central Hospital, Jie fang, Lixia, Jinan, Shandong Province, CHINA.
- 2Department of Pediatrics, Jinan Central Hospital, Jie fang, Lixia, Jinan, Shandong Province, CHINA.
- 3Department of Internal Medicine, Jinan Licheng District Traditional Chinese Medicine Hospital, Hongjialou South, Licheng, Jinan, Shandong Province, CHINA.
- 4Department of Digestive, Jinan Central Hospital, Jie fang, Lixia, Jinan, Shandong Province, CHINA.
CORRESPONDENCE
Lihui Wang
Dr. Jing ZhangDepartment of Digestive, Jinan Central Hospital, Jie fang, Lixia, Jinan, CHINA..
Received: 18-07-2024; Revised: 25-10-2024; Accepted: 13-12-2024.
Volume 59, Issue 2 · pp. 647–654 · PUBLISHED Apr-Jun , 2025 · DOI: 10.5530/ijper.20250344
ABSTRACT
Background Globally, Diabetic Retinopathy (DR) is a leading cause of vision loss. This disease, which impacts the microvasculature of the retina, is brought on by the oxidative stress linked to diabetes. Several studies have shown the anti-diabetic properties of the plant-derived phytochemical "Berberine". However, there is a limited amount of research available on its effects, specifically on Diabetic Retinopathy (DR). Objectives The primary aim of the present investigation is to assess the impact of berberine on DR in rats by examining its underlying influence on oxidative stress, inflammation and programmed cell death. Materials and Methods The current study effectively established a rat model of diabetic retinopathy utilizing Streptozotocin (STZ). The diabetic rats were treated for 12 weeks and evaluated for inflammatory markers (TNF-α, VEGF), antioxidant markers (superoxide, dismutase, catalase and glutathione) and apoptosis markers (Bcl-2, Bax, Cleaved-caspase-3). Results The results demonstrated that Berberine treatment had a significant hypoglycemic index when compared to the diabetic group. Berberine therapy significantly reduced high levels of pro-inflammatory cytokines (TNF-α and VEGF) in the diabetic retina. Berberine also was effective in modulating the antioxidant enzymes and bringing their concentrations to acceptable levels. Berberine treatment also reduced the apoptosis of diabetic mice retina by reducing the elevated ROS level caused by high glucose and reduced the ratio of Bax/Bcl-2 and the expression of cleaved caspase-3. Conclusion Based on the findings, it is possible to infer that Berberine has potential as a pharmacological candidate for the prevention of DR.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Wang, L., Fei, W., Qin, C., & Zhang, J. (2025). Investigating the Anti-Inflammatory, Antioxidant and Apoptotic Protein Inhibition Study of Berberine on Diabetic Retinopathy in Rats. Indian Journal of Pharmaceutical Education and Research, 59(2), 647–654. https://doi.org/10.5530/ijper.20250344
